Trials / Conditions / Embryonal Rhabdomyosarcoma
Embryonal Rhabdomyosarcoma
6 registered clinical trials studyying Embryonal Rhabdomyosarcoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rha NCT05304585 | Children's Oncology Group | Phase 3 |
| Active Not Recruiting | A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarco NCT04994132 | Children's Oncology Group | Phase 3 |
| Recruiting | Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas NCT06669013 | N.N. Petrov National Medical Research Center of Oncology | Phase 3 |
| Active Not Recruiting | Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdo NCT03296371 | Children's Oncology Group | — |
| Recruiting | International PPB/DICER1 Registry NCT03382158 | Children's Hospitals and Clinics of Minnesota | — |
| Active Not Recruiting | Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosar NCT02567435 | National Cancer Institute (NCI) | Phase 3 |